Success Metrics

Clinical Success Rate
84.3%

Based on 237 completed trials

Completion Rate
84%(237/281)
Active Trials
38(10%)
Results Posted
62%(148 trials)
Terminated
44(11%)

Phase Distribution

Ph early_phase_1
6
2%
Ph phase_2
78
20%
Ph phase_4
129
33%
Ph phase_1
62
16%
Ph not_applicable
55
14%
Ph phase_3
47
12%

Phase Distribution

68

Early Stage

78

Mid Stage

176

Late Stage

Phase Distribution377 total trials
Early Phase 1First-in-human
6(1.6%)
Phase 1Safety & dosage
62(16.4%)
Phase 2Efficacy & side effects
78(20.7%)
Phase 3Large-scale testing
47(12.5%)
Phase 4Post-market surveillance
129(34.2%)
N/ANon-phased studies
55(14.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.2%

237 of 303 finished

Non-Completion Rate

21.8%

66 ended early

Currently Active

38

trials recruiting

Total Trials

387

all time

Status Distribution
Active(53)
Completed(237)
Terminated(66)
Other(31)

Detailed Status

Completed237
Terminated44
unknown29
Recruiting26
Withdrawn22
Active, not recruiting12

Development Timeline

Analytics

Development Status

Total Trials
387
Active
38
Success Rate
84.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.6%)
Phase 162 (16.4%)
Phase 278 (20.7%)
Phase 347 (12.5%)
Phase 4129 (34.2%)
N/A55 (14.6%)

Trials by Status

withdrawn226%
suspended21%
terminated4411%
active_not_recruiting123%
enrolling_by_invitation31%
unknown297%
recruiting267%
not_yet_recruiting123%
completed23761%

Recent Activity

Clinical Trials (387)

Showing 20 of 387 trialsScroll for more
NCT07738614Phase 1

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Not Yet Recruiting
NCT06994442Phase 3

Optimizing Pain Treatment in Children On Mechanical Ventilation

Recruiting
NCT03105518Phase 4

Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction

Active Not Recruiting
NCT07525219Phase 3

Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen

Recruiting
NCT07570173Phase 2

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

Recruiting
NCT07571252Phase 4

Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic Surgery

Not Yet Recruiting
NCT07101445Phase 4

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Recruiting
NCT07723352

Journavx to Treat Pain After Thumb Basal Joint Arthroplasty

Enrolling By Invitation
NCT07720791Phase 4

Acetaminophen vs Placebo for Postoperative Analgesia After Abdominal Surgery

Not Yet Recruiting
NCT01059786Phase 2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Active Not Recruiting
NCT04221477Phase 3

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

Active Not Recruiting
NCT07710729Phase 1

A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant

Not Yet Recruiting
NCT07337902Not Applicable

Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

Recruiting
NCT07508241Phase 1

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

Active Not Recruiting
NCT04629248Phase 3

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Active Not Recruiting
NCT06658574Phase 2

Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients

Completed
NCT03805932Phase 1

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Active Not Recruiting
NCT04165096Phase 2

KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

Completed
NCT01739699Phase 4

The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period

Completed
NCT03978767Phase 2

Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial

Completed

Drug Details

Intervention Type
DRUG
Total Trials
387